Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis

Analysis of cytomegalovirus DNA polymera

Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis

✍ Guy Boivin; Nathalie Goyette; Christian Gilbert; Emma Covington 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

## Abstract We previously reported the absence of CMV __UL97__ (kinase) gene resistance mutations up to 12 months post‐transplant following 100 days of valganciclovir prophylaxis, and a low incidence of resistance mutations following 100 days of oral ganciclovir prophylaxis in a prospective multice